Clinical Trials · NCT07073417
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Enrollment
- 163
- Start date
- Jul 2025
- Locations
- 1 site, China
- Primary endpoint
- Percentage change in body weight relative to baseline